文献速递哮喘

吸入性糖皮质激素对轻度哮喘患者气道重塑的影响

[Effect of inhaled corticosteroids on airway remodeling in patients with mild asthma].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2025-01-01

本研究为单臂、开放标签、单中心、前瞻性探索性研究,纳入15例初诊轻度哮喘患者,给予丙酸氟替卡松吸入气雾剂125 μg/次、2次/d规律治疗12个月。结果显示第12个月时CT测量的3、4、5、6级支气管Ai增加、Aw%减少(均P<0.05),基底膜和上皮厚度显著变薄,且Aw%、上皮和基底膜厚度变化与ACT评分改善显著相关(均P<0.05)。结论为规律吸入ICS 12个月可减轻轻度哮喘患者气道重塑。

要点

  • 轻度哮喘患者规律吸入ICS 12个月可减轻气道重塑。
  • CT显示3–6级支气管管腔面积增加、管壁厚度百分比减少。
  • 气道重塑改善与ACT评分改善显著相关。

核心结论

  • 轻度哮喘患者规律吸入ICS 12个月后气道重塑程度减轻,表现为气道管壁厚度变薄,气道黏膜上皮和基底膜变薄。
  • 气道重塑的改善与哮喘ACT评分的改善显著相关。

研究设计与样本

  • 单臂、开放标签、单中心、前瞻性探索性研究,纳入2019年1月至2020年12月广东药科大学附属第一医院初诊轻度哮喘患者15例(男6例,女9例,年龄38.6±11.5岁)。

主要发现

  • 第12个月时CT测量的双下叶3、4、5、6级支气管Ai分别增加7.5%、14.4%、4.1%、22.8%,Aw%分别减少6.1%、6.7%、6.5%、7.0%(均P<0.05)。
  • 基线气道平滑肌面积13.3%±8.7%,第12个月时为11.7%(6.0%,15.0%),未发生显著改变(Z=-0.63,P=0.539)。
  • 基底膜厚度从基线(5.19±1.75)μm降低为第12个月(3.83±1.15)μm(Z=-2.38,P=0.019)。
  • 上皮厚度从基线(78.60±13.12)μm降低为第12个月(59.32±11.97)μm(t=4.20,P<0.001)。
  • 第12个月时Aw%、上皮和基底膜厚度的变化值均与ACT评分改善程度显著相关(均P<0.05)。

关键数值与推荐

  • 丙酸氟替卡松吸入气雾剂125 μg/次、2次/d规律治疗12个月。

临床怎么用

  • 在气道形态和结构层面为轻度哮喘以ICS为基础的控制治疗提供了理论依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the effect of inhaled corticosteroids on airway remodeling in patients with mild asthma. Methods: In this single-arm, open-label, single-center, prospective exploratory study, we enrolled patients with mild asthma from January 2019 to December 2020 at the First Affiliated Hospital of Guangdong Pharmaceutical University. A total of 15 patients with mild asthma were included in this study. There were 6 males and 9 females. The age was (38.6±11.5) years. Fluticasone propionate inhalation aerosol (125 μg) was administered twice daily for 12 months. Pulmonary function tests, high-resolution chest CT, asthma control test (ACT) questionnaires were performed before and after treatment. Airway mucosal biopsies and bronchoalveolar lavage fluid were obtained by bronchoscopy of the right lower lobe to evaluate the airway inflammatory condition. Airway lumen area (Ai), airway wall thickness (Aw%) measured by CT, and the thickness of airway epithelium, basement membrane and smooth muscle measured by pathology were analyzed to evaluate the effect of inhaled corticosteroid on airway remodeling. Pearson or Spearman correlation were used to analyze the correlation among the improvement in lung function, ACT score and the improvement of airway remodeling. Results: The Ai at 3, 4, 5, and 6th generation of bronchi was increased by 7.5%, 14.4%, 4.1%, and 22.8%, respectively; The Aw% was decreased by 6.1%, 6.7%, 6.5%, and 7%, respectively (all P< 0.05). The average area of airway smooth muscle was 13.3%±8.7% at baseline, and was 11.67% at the 12th month (interquartile range 9%), but the change was not significant (Z=-0.63, P=0.539). The thickness of the basement membrane decreased from (5.19±1.75) μm to (3.83±1.15) μm at the 12th month (Z=-2.38, P=0.019). The thickness of the epithelium decreased from (78.60±13.12) μm to (59.32 ±11.97) μm at 12 month (t=4.20, P<0.001). Changes in Aw%, epithelial and basement membrane thickness at the 12th month were correlated with the improvement in ACT score (all P<0.05). Conclusions: Regular inhalation of corticosteroids for 12 months in patients with mild asthma resulted in reduced airway remodeling, as evidenced by a decrease in the thickness of airway wall, airway mucosal epithelium and basement membrane. The improvement of airway remodeling was significantly associated with the improvement of asthma ACT score. A scientific rationale for inhaled corticosteroids in mild asthma on airway remodeling was provided at the level of morphology and structure. 目的: 评价吸入性糖皮质激素(ICS)对初诊轻度支气管哮喘(哮喘)患者气道重塑的作用。 方法: 本研究为一项单臂、开放标签、单中心、前瞻性研究,共纳入2019年1月至2020年12月广东药科大学附属第一医院初诊的轻度哮喘患者15例,其中男6例,女9例,年龄(38.6±11.5)岁。给予丙酸氟替卡松吸入气雾剂吸入125 μg/次、2次/d规律治疗12个月。患者治疗前后分别行肺功能、胸部高分辨率CT检查,填写哮喘控制测试(ACT)问卷,并行气管镜检查采集右下叶基底段支气管黏膜组织。分析患者ICS治疗前后CT测量的气道管腔面积(Ai)、气道管壁厚度(Aw%)和病理测量的气道上皮、基底膜和平滑肌厚度,评价ICS对气道重塑的作用。使用Pearson或Spearman相关分析来分析患者肺功能、ACT评分的改善与气道重塑改善的关系。 结果: 患者吸入ICS第12个月时CT测量的双下叶3、4、5、6级支气管Ai分别增加了7.5%、14.4%、4.1%、22.8%,Aw%分别减少了6.1%、6.7%、6.5%、7.0%(均P<0.05)。基线气道平滑肌面积13.3%±8.7%,第12个月时为11.7%(6.0%,15.0%),未发生显著改变(Z=-0.63,P=0.539);12个月时基底膜和上皮厚度显著变薄,基底膜厚度从基线时的(5.19±1.75)μm降低为(3.83±1.15)μm(Z=-2.38,P=0.019);上皮厚度从基线时的(78.60±13.12)μm降低为(59.32±11.97)μm(t=4.20,P<0.001)。第12个月时Aw%、上皮和基底膜厚度的变化值均与ACT评分改善程度显著相关(均P<0.05)。 结论: 轻度哮喘患者规律吸入ICS 12个月后气道重塑程度减轻,表现为气道管壁厚度变薄,气道黏膜上皮和基底膜变薄。气道重塑的改善与哮喘ACT评分的改善显著相关。在气道形态和结构层面为轻度哮喘以ICS为基础的控制治疗提供了理论依据。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li XY, Zhang SQ, Xing QY, et al. [Effect of inhaled corticosteroids on airway remodeling in patients with mild asthma]. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40050075. doi:10.3760/cma.j.cn112147-20240724-00428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。